In vitro diagnosis refers to products and services that obtain clinical diagnostic information by testing human samples outside the human body, and then determine diseases or body functions. They are playing an increasingly important role in clinical medicine and related medical research fields. In recent years, with the introduction of a series of favorable policies, the domestic in vitro diagnostic industry has developed rapidly. Beijing Diagreat Biotechnologies Co., Ltd. from the sub-center of the city is a typical representative.

Click on the image for more information about the news

Beijing Tongzhou Release: Lu Xueying, Wang Zhi, the media reported that Diagreat Biotechnologies insisted on independent research and development, conquered key upstream raw materials, mastered core technologies, make the city's sub-center manufacturing go abroad, and its products are sold worldwide. #IVD

(Interview) Beijing Diagreat Biotechnologies Co., Ltd. marketing: 'The Therapeutic Drug Monitoring (TDM) series of products are used to monitor drug concentration, because there is a class of drugs that one point more is poisonous, and one point less is ineffective. Therefore we monitor the concentration of the drug, which can be more conducive to the doctor's diagnosis and individualized precise medication.'

The '14th Five-Year Plan for the Development of the Pharmaceutical Industry' pointed out that China will vigorously promote the research and development of innovative products, focusing on the development of medical devices in the field of in vitro diagnostics, various molecular diagnostic products required for disease screening and precision medicine. Based on independent innovation, Diagreat has successively won many honors such as 'National High and New Tech Enterprise', ' Zhongguancun High and New Tech Enterprise', ' Beijing 'Specialized, Excellent, Featured and Innovative' Small and Medium-sized Enterprise', 'Beijing Golden Seed Enterprise'.